Gulf Medical Projects Company (PJSC) First Quarter 2025 Earnings: EPS: د.إ0.032 (vs د.إ0.024 in 1Q 2024)

Simply Wall St

May 17, 2025

Gulf Medical Projects Company (PJSC) (ADX:GMPC) First Quarter 2025 Results

Key Financial Results

Revenue: د.إ180.1m (up 7.8% from 1Q 2024).
Net income: د.إ22.5m (up 34% from 1Q 2024).
Profit margin: 13% (up from 10% in 1Q 2024). The increase in margin was driven by higher revenue.
EPS: د.إ0.032 (up from د.إ0.024 in 1Q 2024).

Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.

earnings-and-revenue-history — ADX:GMPC Earnings and Revenue History May 17th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Gulf Medical Projects Company (PJSC) shares are up 9.7% from a week ago.

Risk Analysis

You should learn about the 2 warning signs we've spotted with Gulf Medical Projects Company (PJSC) (including 1 which makes us a bit uncomfortable).

If you're looking to trade Gulf Medical Projects Company (PJSC), open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.

With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.

Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.